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Abstract
Total antigens from Leishmania braziliensis promastigotes, solubilized with sodium cholate
(dsLp), were formulated within ultradeformable nanovesicles (dsLp-ultradeformable
archaeosomes, (dsLp-UDA), and dsLp-ultradeformable liposomes (dsLp-UDL)) and topi-
cally administered to Balb/c mice. Ultradeformable nanovesicles can penetrate the intact
stratum corneum up to the viable epidermis, with no aid of classical permeation enhancers
that can damage the barrier function of the skin. Briefly, 100 nm unilamellar dsLp-UDA (soy-
bean phosphatidylcholine:Halorubrum tebenquichense total polar lipids (TPL): sodium cho-
late, 3:3:1 w:w) of -31.45 mV Z potential, containing 4.84 ± 0.53% w/w protein/lipid dsLp,
235 KPa Young modulus were prepared. In vitro, dsLp-UDA was extensively taken up by
J774A1 and bone marrow derive cells, and the only that induced an immediate secretion of
IL-6, IL-12p40 and TNF-α, followed by IL-1β, by J774A1 cells. Such extensive uptake is a
key feature of UDA ascribed to the highly negatively charged archaeolipids of the TPL,
which are recognized by a receptor specialized in uptake and not involved in downstream
signaling. Despite dsLp alone was also immunostimulatory on J774A1 cells, applied twice a
week on consecutive days along 7 weeks on Balb/c mice, it raised no measurable response
unless associated to UDL or UDA. The highest systemic response, IgGa2 mediated, 1 log
lower than im dsLp Al2O3, was elicited by dsLp-UDA. Such findings suggest that in vivo,
UDL and UDA acted as penetration enhancers for dsLp, but only dsLp-UDA, owed to its
pronounced uptake by APC, succeeded as topical adjuvants. The actual TPL composition,
fully made of sn2,3 ether linked saturated archaeolipids, gives the UDA bilayer resistance
against chemical, physical and enzymatic attacks that destroy ordinary phospholipids bilay-
ers. Together, these properties make UDA a promising platform for topical drug targeted
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delivery and vaccination, that may be of help for countries with a deficient healthcare
system.
Introduction
Vaccination is considered the best hope for control of all forms of leishmania diseases, and the
development of a safe, effective and affordable antileishmanial vaccine is a critical global pub-
lic-health priority [1]. Nanovaccination, an approach relying on the higher uptake of nanopar-
ticles compared to that of soluble material by antigen presenting cells (APC), results in
enhanced antigen processing, lymphocyte priming and subsequent adaptive immune response.
A growing number of ad-hoc designed nanoparticles is being tested as first (soluble or nano-
particle associated antigens without immunomodulatory activity) or second (nanoparticle
associated antigens with immunomodulatory activity) generation adjuvants [2], entering clini-
cal trials and commercialization [3]. The nanovaccination approach offers a new portfolio of
adjuvants, which may help to overcome the challenges of vaccinating in countries of poor sani-
tary infrastructure, lacking of trained personnel, cold chain maintenance, proper waste man-
agement, syringes sterilization.
Probably because of its character of neglected disease, up to the moment no commercial
vaccine is available to prevent the muco-cutaneous leishmaniasis (MCL), a highly morbid,
inflammatory and disfiguring infection, mostly prevalent in Southamerica [4]. One of the fac-
tors contributing to slow down its development is the important genetic and biological diver-
gence amongst L.major /L. infantum and L. braziliensis [5], which demands that polyvalent
vaccines include a critical fragment of L. braziliensis antigens [6–8]. The recombinant antigens
LEISH F1, is a protein comprised of three fragments conserved across various Leishmania spe-
cies including L. donovani, and L. chagasi, causative agents of NewWorld visceral leishmania-
sis, and L. braziliensis [9, 10]. A vaccine in development by the Infectious Disease Research
Institute (IDRI, Seattle, WA) and currently in phase I and II clinical trials combines LEISHF1
with the powerful adjuvants MPL-SE. The last consists of the TLR4 ligand Monophosphoryl
Lipid A, an attenuated form of Lipid A from Salmonella Minnesota R595 (GSK), in a stable oil-
in-water emulsion (made of squalene, Pluronic F68, glycerol, α-tocopherol and phospholipids).
Squalene emulsions adjuvanted vaccines, although used against life threatening infections,
have raised a number of concerns; are said for instance, to be excellent for priming, but not to
boost pre existing immune responses well [11], other have been associated with narcolepsy in
children and adolescents in northern European countries [12]. Emulsion adjuvants in general
can bring also stability challenges for many antigens, particularly if a single dose liquid vial is
preferred [13]. Whereas the overall risk benefit in prophylactic vaccination against pandemic
and prepandemic lethal viral fevers was declared positive by the WHO [14], the use of squalene
emulsions to adjuvant vaccines against a disease caused by a non lethal protozoan parasite is at
least uncertain.
In this scenario, developing adjuvants different from squalene-containing o/w emulsions
for vaccination against protozoan becomes an attractive subject to address. For instance, an
initial study performed in our laboratory using for the first time archaeosomes, nanovesicles
made of total polar lipids (TPL) from the hyperhalophile archaea Halorubrum tebenqui-
chense, to immunize C3H/HeN mice against the model antigen bovine serum albumin,
showed these archaeosomes recalled antigen specific Th1 biased and memory responses [15].
Later, we found that 3 sc doses of Trypanosoma cruzi (a protozoan trypanosomatide parasite
close to Leishmania) total antigens adjuvanted with the same archaeosomes, were sufficient
to protect Balb c mice from a lethal challenge with trypomastigotes of the Tulahuen strain
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[16]. These result encouraged us to test novel adjuvants containing TPL from H. tebenqui-
chense, to elicit protective responses against protozoan parasites by non parenteral route.
Topical and mucosal vaccines offer several advantages over injectables: are easier to adminis-
ter, carry less risk of transmitting infections, and could simplify the manufacture process,
thereby facilitating vaccine production and mass deployment [17]. Because of this, the pres-
ent proof of concept is aimed to test the immune response by topical nanovaccination on
Balb/c mice, to proteins extracted from Leishmania braziliensis. To that aim the proteins
were loaded within nanovesicles having the same TPL than original archaeosomes, plus an
edge activator that decreases the Young modulus of the bilayer, named ultradeformable
archaeosomes (UDA). More specifically, the UDA are ultradeformable nanovesicles made of
soybean phosphatidylcholine (SPC): sodium cholate (NaChol) and TPL at 3: 1: 3 w: w. The
actual TPL composition, fully made of sn 2,3 ether linked saturated archaeolipids, gives the
archaeosomes bilayer resistance against chemical, physical and enzymatic attacks that
destroy ordinary phospholipids bilayers [18]. The same as archaeosomes, UDA display
higher chemical and colloidal stability than the so called ultradeformable liposomes (UDL,
nanovesicles made of SPC:NaChol 6:1 w:w), (unpublished results). The same as UDL, upon
topically applied under non occlusive conditions, the UDA can penetrate the intact stratum
corneum up to the viable epidermis, with no aid of classical permeation enhancers that can
damage the barrier function of the skin. The TPL content of UDA is responsible for its much
more pronounced capture by phagocytic /immature antigen presenting cells than UDL [19].
Such properties, together with higher physic-chemical and colloidal stability make UDA a
promising platform for topical drug targeted delivery and adjuvancy, that may be of help for
countries with a deficient healthcare system. To the best of our knowledge, this is the first
report proposing a needle free vaccination strategy against CL from a NewWorld leishmania
specie.
Materials and Methods
Materials
Soybean phosphatidylcholine (SPC) (phospholipon 90 G, purity>90%) was a gift from Phos-
pholipid/Natterman, Germany. Sodium cholate (NaChol), 1,2-Dimyristoyl-sn-glycero-3-phos-
phoethanolamine-N-(Lissamine™ rhodamine B sulfonyl) (Rh-PE), Sephadex G-75, 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), aluminiumnitrat nonahy-
drat (Al(NO3)3 x 9H2O), 2,2'-Azino-bis(3-Ethylbenzthiazoline-6-Sulfonic Acid) (ABTS), Lipo-
polysaccharides from Escherichia coli (LPS) and horseradish peroxidase conjugated anti-mouse
IgA antibody were from Sigma-Aldrich (St Louis, MO, USA). Anti-mouse IgG1 and IgG2a
were from Santa Cruz Biotechnology. Horseradish peroxidase conjugated anti-mouse IgG was
from Chemicon International Millipore. Roswell Park Memorial Institute (RPMI) 1640 and
modified Eagle’s medium (MEM) were from Gibco1, Life Technologies (New York, USA).
Fetal calf serum (FCS), antibiotic/antimycotic solution (penicillin 10,000 IU/ml, streptomycin
sulfate 10 mg/mL, amphotericin B 25 μg/ml), glutamine, and trypsin/ethylenediaminetetraace-
tic acid were from PAA Laboratories GmbH (Pasching, Austria). Complete RPMI (comp-
RPMI) was prepared with RPMI 1640, 10% FCS, 5.5×10−5 M β-mercaptoethanol from Sigma-
Aldrich, and antibiotic/antimycotic solution. Dendritic cell RPMI (DC-RPMI) was prepared
with comp-RPMI plus 100 IU/ml of murine recombinant granulocyte-macrophage colony-
stimulating factor (rmGM-CSF) (Pepro Tech, Rocky Hill, NJ, USA). All other chemicals and
reagents were of analytical grade.
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Archaebacteria growth, extraction and characterization of total polar
lipids
Halorubrum tebenquichense archaeas, isolated from soil samples of Salina Chica, Península de
Valdés, Chubut, Argentina were grown in 8 L batch cultures in basal medium supplemented
with yeast extract and glucose [15]. Cultures were monitored by absorbance at 660 nm and har-
vested in late stationary phase for storage as frozen cell pastes.
Total lipids were extracted from frozen and thawed biomass using the Bligh and Dyer
method modified for extreme halophiles and the Total Polar Lipid (TPL) fraction was collected
by precipitation from cold acetone [20]. Between 90 and 120 mg TPL were isolated from each
culture batch. The reproducibility of each TPL extract´s composition was routinely screened
by phosphate content [21] and electro spray ionization mass spectrometry (ESI-MS) as
described in Higa et al. 2012 [19].
Cells
Keratinocytes and macrophages. Human keratinocytes (HaCaT cells) were supplied by
Dr. Salvatierra of Fundación Instituto Leloir (Buenos Aires, Argentina) and murine macro-
phages (J774A.1 cells) were supplied by Dr. Ugalde from Instituto de Investigaciones Biotecno-
lógicas, Universidad de San Martin (Buenos Aires, Argentina). Cells were routinely cultured in
MEM supplemented with 10% FCS, 1% antibiotic/antimycotic and 2 mM glutamine, at 37°C
in 5% CO2 and 95% humidity.
Leishmania parasites. Leishmania braziliensis promastigotes (strain HOM/BR75/M2903)
supplied by Dr. Fragueiro and Dr. Luna from Instituto Nacional de Parasitología Dr Mario
Fatala Chaben were cultured at 26°C in Schneider culture medium supplemented with 10%
FCS, 100 U/ml penicillin, 100 μg/ml streptomycin and 2 mM glutamine. Promastigotes were
harvested from stationary phase cultures by centrifugation, washed three times with 10 mM
Tris buffer plus 0.9% w/v NaCl, pH 7.4 (Tris buffer) and frozen at -20°C prior to use.
Bone marrow-derived dendritic cells (BMDCs). Six-month old Balb/c mice were used as
bone marrow donors. BMDCs were generated as described previously [22]. Briefly, after all muscle
tissues were removed from the femurs, the bones were washed twice with phosphate-buffer saline
(pH 7.4) (PBS) and transferred into a fresh dish with RPMI 1640 medium. Both ends of the bones
were cut with scissors in the dish. Then the marrow was flushed out using 2 ml of RPMI 1640 with
a syringe and 25-gauge needle. The tissue was suspended and passed through a 100 μm cell strainer
(BD Falcon, Franklin Lakes, NJ, USA) to remove small pieces of bone and debris. Red cells were
lysed with 0.45 M ammonium chloride, and the remaining cells were washed, and suspended at a
concentration of 1 × 106 cells/ml in DC-RPMI medium with two additional supplementation of
medium containing rmGM-CSF in 100 mm Petri dishes (5 x106 cells/dish). After 9 days of culture,
approximately 80% of the harvested cells expressedMHC class II and CD11c.
Preparation of detergent-solubilized L. braziliensis proteins
A whole-cell extract was prepared as described by Santos et al., 2006. Briefly, stationary phase
promastigotes were washed three times in Tris buffer (5 min centrifuged at 250 g) disrupted by
10 freeze and thaw cycles, and submitted to probe-type ultrasonication (Sonics Vibra cell) at
50% amplitude (130 Watts), for 10 min in an ice bath. The protein concentration in the whole-
cell extract was estimated by Bradford using ovalbumin as standard [23].
To obtain the detergent-solubilized L. braziliensis proteins (dsLp), the whole-cell extract of
L. braziliensis was incubated with 10, 5 or 1.25% w/v NaChol for 45 min at 4°C; the resultant
dsLp was recovered from filtration through 0.45 μm pores nylon filter.
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Whole-cell extract and dsLp were run by electrophoresis in 7.5–15% linear gradient sodium
dodecyl sulfate-polyacrylamide gels (SDS-PAGE) [24]. Briefly, the samples were mixed with
62.5 mM Tris-HCl pH 6.8; 2% w/v SDS, 10% v/v glycerol, 5% v/v β-mercaptoethanol and
0.001% w/v bromophenol blue and heated at 95°C for 5 min prior electrophoresis. Proteins
were separated at a constant voltage of 100 V, using a running buffer containing 0.025 M Tris,
0.192 M glycine pH 8.3 and 0.1% w/v SDS. The staining was performed with Coomassie Bril-
liant Blue R-250 followed by silver staining. The ImageJ software (National Institutes of Health,
Bethesda, MD) was used to scan the 63 kDa band of the dsLp, and to quantify the amount of
dsLp associated to UDA or UDL. To that aim, a plot of the signal of growing amounts of dsLp
protein vs mass protein (5–30 μg) was fitted by linear regression. Then the dsLp signal in UDA
or UDL was extrapolated to render the actual protein mass associated to each nanovesicle.
Preparation and characterization of nanovesicles
Preparation. Empty nanovesicles: ultradeformable archaeosomes (UDA, made of TPL:
SPC:NaChol, 3:3:1 w:w), ultradeformable liposomes (UDL, made of SPC:NaChol, 6:1 w:w) and
conventional liposomes (L, fully made of SPC); and dsLp-containing nanovesicles: dsLp-con-
taining UDA (dsLp-UDA) and dsLp-containing UDL (dsLp-UDL), were prepared by the thin
film hydration method.
Empty nanovesicles: appropriate amounts of SPC in chloroform, and TPL and NaChol in
chloroform: methanol (1:1, v/v), were mixed in round bottom flasks. Solvents were rotary evap-
orated at 40°C until elimination, the lipid films were flushed with N2 and hydrated with aque-
ous phase (Tris-HCl buffer) up to a final concentration of 43 mg of phospholipids/ml followed
by extrusion.
dsLp-containing nanovesicles: the lipid films were prepared as detailed above, but hydrated
with dsLp having NaChol at 10, 5 and 1.25% w/v in Tris-HCl buffer) up to 43 mg of phospho-
lipids/ml. The resultant suspensions were sonicated (45 minutes with a bath-type sonicator 80
W, 40 KHz) and extruded 15 times through three stacked 0.2–0.1- and 0.1-μm pore size poly-
carbonate filters using a 100 ml Thermobarrel extruder (Northern Lipids, Vancouver, Canada).
After extrusion, nanovesicles were submitted to five freeze-thaw cycles between −70°C and
40°C. Finally, nanovesicles were separated from free dsLp by gel filtration on Sephadex G-75
using the minicolumn centrifugation technique [25].
Rh-PE-labelled vesicles: Rh-PE was dissolved in chloroform and 12.5 nmol was added to the
organic solution of lipids (nearly 2800:1 w:w phospholipids:Rh-PE); nanovesicles were pre-
pared as detailed above.
Quantification. Phospholipids were quantified by Bötcher microassay [21]. The dsLp pro-
teins associated to UDA or UDL was quantified as stated in Preparation of detergent-solubilized
L. braziliensis proteins.
Size and Z potential. Size and Zeta potential were determined by dynamic light scattering
(DLS) and phase analysis light scattering (PALS) respectively, using a nanoZsizer apparatus
(Malvern Instruments, Malvern, United Kingdom).
Morphology. Aliquots of nanovesicles were dropped on a standard carbon-coated cooper
transmission electron microscopy (TEM) grid and then air-dried at room temperature overnight.
TEM images were obtained with a JEM 1011 (Jeol, New York, NY) electron microscope at 80 kV.
Aliquots of nanovesicles diluted in Tris buffer with 10 mM CaCl2 were dropped on mica as
the substrate. Vesicles were stood for 15 min to be washed with 1 ml of Milli-Q water. Atomic
force microscopy (AFM) images were obtained with a Multimode Scanning Probe Microscope
(Veeco, Santa Barbara, CA) equipped with a Nanoscope V controller operating in tapping
mode at room temperature.
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Deformability. The nanovesicles deformability (D) was calculated according to Van den
Bergh [26], having D = J(rv/rp)2, where J is the rate of penetration through a permeability bar-
rier, rv is the size of nanovesicles after extrusion, and rp is the pore size of the barrier. To mea-
sure J, nanovesicles were extruded through two stacked 50 nm (rp) membranes at 0.8 MPa
using a Thermobarrel extruder. Extruded volume was collected along 15 min, each fraction
was quantified for phospholipids, and J calculated as the area under the curve of the plot of
recovered phospholipids as a function of time. The average vesicle diameter after extrusion (rv)
was measured by DLS.
Young Modulus determination through Atomic Force Microscopy (AFM)
Sample preparation and Force Curves acquisition. The mechanical properties of con-
ventional, non ultradeformable (SPC), empty (UDA, UDL) and dsLp nanovesicles were deter-
mined as described by Arnal et al. 2012 [27]. All the measurements were done using a
Multimode Scanning Probe Microscope (Veeco, Santa Barbara, CA) equipped with a Nano-
scope V controller. The nanovesicles were electrostatically immobilized onto polyethylenei-
mine (0.1% w/v) pre-incubated glass slides and immediately mounted in the AFM liquid
chamber. Fifty microliters of PBS were added to the chamber in order to maintain the samples
hydrated during the course of the experiments. The measurements were done using contact
sharpened silicon nitride probes (NP-10, Veeco) with a nominal tip radius between 20–60 nm.
The cantilever spring constant (Kc) was determined for every probe before starting the mea-
surements using the Thermal Tune method and flat muscovite mica (SPI V-1 grade) as a flat
rigid surface for photodetector sensitivity calibration, the experimental Kc values were between
0.08 and 0.13 N/m. To acquire the Force vs. Distances curves on the surface of nanovesicles the
Force Volume (FV) tool with a routine of 32 x 32 force curves at a scan rate of 1Hz was used.
Note that different scan rates within 0.1 and 2 produced similar results. A limit in the highest
applied force (10 nN) was established in order not to damage the samples during the FV
acquisition.
Force curves analysis and Young Modulus determination. The nanoindentation analysis
was done using in house developed software [27] following previously described procedures
[28–30]. First we determined the contact point of the force curves; which was done manually
by determining the exact point were the curves begin to lift from the noncontact baseline. Then
the approximation segment of the Force vs. Distance curves were transformed into Force vs.
Indentation curves by subtracting at constant loading force the Z-displacement measured in a
vesicle and the respective Z-displacement measured on a hard surface (clean flat mica). All the
resulting Force vs. Indentation curves showed a non-linear behaviour at low force, which were
fitted using a Hertz model to determine the Young Modulus. The selected Hertz model was the
one that considers a conical tip shape since it was the model that bests fitted our experimental
data. The equation for the Hertz model [31, 32] is the following: F = 2E tanα δ2/π (1-ν2); where
F is force, E is the Young Modulus, α is the half opening angle of the conical indenter (53°;
based in geometrical characteristics of the tip and scanning electron microscopy observations),
δ is the indentation and ν is the Poisson radius which for soft biological samples is assumed to
be 0.5 [33, 34].
Viability of keratinocytes, macrophages and bone marrow-derived
dendritic cells
HaCaT, J774A.1 cells and BMDCs were seeded at a density of 5 x 104 and 9 x 104 cells per well,
respectively, onto 96-well flat-bottom plates and grown for 24 h at 37°C. Then, the medium
was replaced by 100 μL of fresh medium with 5% FCS containing decreasing concentrations of
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empty UDA/UDL or dsLp- UDA/UDL in a half-fold dilution series (1.6 to 0.2 mg/ml of phos-
pholipids, corresponding to 72 to 9 μg/ml of dsLp in UDL and 56 to 7 μg/ml of dsLp in UDA)
or dsLp alone (200 to 50 μg/ml) and cells were incubated at 37°C for 24 h. After that, the
medium was removed and replaced by 0.5 mg/ml of MTT. After 3 hours of incubation, the
MTT solution was removed, the insoluble formazan crystals were dissolved in dimethyl sulfox-
ide, and absorbance was measured at 570 nm in a microplate reader (Dynex Technologies,
MRX tc, Chantilly, Virginia). The cell viability was expressed as a percentage of the viability of
cells grown in medium.
Pro-inflammatory cytokine production
J774A.1 and BMDCs were seeded at a density of 5 x 104 cells per well onto 24-well plates and
grown for 24 h at 37°C. Then, the medium was replaced by fresh medium with 5% FCS con-
taining: empty UDA and UDL, dsLp-UDA and dsLp-UDL (0.8 mg/ml phospholipids), dsLp
alone (10 and 50 μg/ml) and LPS (1 μg/ml). Supernatants were collected at 14 h and 48 h and
TNF-α, IL12p40, IL 6 and IL1-β production were measured by ELISA using a BD Kit.
Nanovesicles uptake by BMDC
The uptake of Rh-PE-labeled nanovesicles by BMDCs was determined by flow cytometry.
BMCDs cells seeded at a density of 3.5×105 cells per well onto 6-well microplates were grown
for 24 h at 37°C. The medium was replaced with fresh RPMI with 5% FCS containing Rh-PE-
labeled nanovesicles, UDA and UDL at 0.8 mg/ml phospholipids, and cells were incubated for
1, 3, and 5 h at 37°C. After incubation, the supernatant was removed and loose cells were
washed with PBS. Cells were suspended in PBS, and a total of 1 x 105 cells were analyzed by
flow cytometry (BD FACSCalibur™; BD Biosciences, San Jose, CA, USA). Data were analyzed
using WinMDI 2.9 software (Microsoft, Redmond, WA, USA).
Immunization
Male 6-8-week-old Balb/c mice were obtained from Facultad de Ciencias Veterinarias, Univer-
sidad Nacional de La Plata. Mice were housed 5 per cage and keep in a ventilated room under
controlled conditions at constant room temperature 22°C, with 12/12 h light-dark cycle and
free access to food and water. All procedures requiring animals were performed in agreement
with institutional guidelines and were approved by the Committee on the Ethics of Animal
Experiments of the National University of Quilmes, Argentina. All animals were treated in a
humance way, following the guidelines listed in “Guide for the Humance Care and Use of Lab-
oratory Animals” (NIH publication). Five mice per group were immunized according to the
schemes shown in Table 1. Topical samples were dropped on manually trimmed hair, intact
Table 1. Immunization scheme.
Route of Sample Dose (μg dsLp/ Days of immunization
administration 50 μl μg phospholipid
Intramuscular dsLp-Al2O3 36/- 0, 21
Topical dsLp 36/- Once a week for 7 weeks
Topical dsLp-UDA 43/1205 Twice a week on consecutive days for 7 weeks
Topical dsLp-UDL 50/1115 Twice a week on consecutive days for 7 weeks
dsLp-UDA, detergent-solubilized L. braziliensis proteins-containing- ultradeformable archaeosomes; dsLp-UDL, detergent-solubilized L. braziliensis
proteins containing ultradeformable liposomes
doi:10.1371/journal.pone.0150185.t001
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back skin surface of each mouse over an area of 2 cm2. Mice were kept in individual cages for
30 min until drops had dried. At the end of experimentation (3 months) animals were eutha-
nized by cervical dislocation.
Blood was collected from the tail veins at weekly intervals up to 8 weeks. Salivary washes
were collected at 0, 35 and 49 days. To that aim, 100 μl of pilocarpine-HCl (1mg/ml in PBS)
were i.p injected and after 1 min, the saliva was collected with a micropipette without damaging
the gingival tissue. The samples were kept frozen at -20°C until use.
IgG antibody and isotypes in blood samples and IgA antibody in salivary washes samples
were analyzed by ELISA. Briefly, microtiter plates were coated overnight at 4°C with 45 μg/ml
dsLp in 0.1 M carbonate-bicarbonate buffer (pH 9.6) and then blocked with PBS containing
0.2% Tween 20 (0.2% PBST) for 1 h at 37°C after washing with 0.05% PBST. After another
washing, 100 μL of three-fold dilutions of individual sera in 0.05% PBST was added. After 2 h
at 37°C and further washing, the plates were incubated for 1 h at 37°C with horseradish peroxi-
dase-conjugated goat anti-mouse IgG diluted 1:2000 in 0.025% PBST. To determine the anti-
body isotyping, horseradish peroxidase-conjugated rat anti-mouse IgG1 or IgG2a revealing
antisera, diluted 1:1000, were used. The plates were further washed and incubated with ABTS
for 10 min at room temperature in the dark. The absorbance was measured at 405 nm using a
microplate reader. Antibody titers were represented as end-point dilutions exhibiting an opti-
cal density of 0.3 units above background.
The IgA titers of salivary washes were determined in the same fashion.
Statistical analysis
Statistical analyses were performed by one-way analysis of variance followed by Turkey’s test
sing Prisma 4.0 Software (Graph Pad, San Diego, California). Significance levels are shown in
figure legends.
Results
Characterization of nanovesicles containing detergent-solubilized
leishmania proteins
Both the whole-cell extract of leishmania promastigotes and its supernatant have been indis-
tinctly used as antigenic material in in vitro tests and as pre-clinical and clinical vaccine candi-
dates [35–37]. Besides, it has been observed that detergent-solubilized proteins of a crude
extract of L. amazonensis amastigotes reconstituted in dipalmitoylphosphatidylcholine: dipal-
mitoylphosphatidylserine: cholesterol nanovesicles, produce protein specific antibodies and
partially protects Balb/c mice to infection with L. amazonensis promastigotes [38]. Moreover,
the centrifugation pellet of the whole-cell extract from L. amazonensis and L. braziliensis pro-
mastigotes was reported to be more antigenic than the supernatant [37].
Formulating voluminous antigens higher than small model proteins within UD nanovesi-
cles however, proved complex. For instance, attempts to solubilize the lipid film with whole-
cell extract-containing buffer (or its centrifugation pellet) led to macroscopic precipitate (data
not shown). To overcome such drawback, the whole cell extract was solubilized as smaller
mixed micelles, which could be fully suspended in aqueous media, making feasible their trap-
ping within the inner space of nanovesicles. The whole-cell extract of leishmania promastigotes
can be solubilized employing different hydrophilic/hydrophobic balance and critical micellar
concentration (cmc) detergents, such as sodium deoxycholate, NaChol, sodium dodecylsul-
phate or octylglucopiranoside [38–41]. We chose NaChol because it forms part of UDL and
UDA bilayers as the edge activator and because of its non denaturing character. The cmc of
Adjuvancy of Ultradeformable Archaeosomes
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NaChol is 0.6–0.7% w/v; above that limit, micelles of 14 nm size are formed; at 1% w/v, NaChol
is known to solubilize more than 90% axonal membrane proteins of bovine brain [42]. We
found that 1.25% w/v NaChol solubilized the whole-cell extract as 25 nm mixed micelles
(dsLp) of 4.8 mg/ml proteins and 3.3 mg/ml phosphate. The SDS-PAGE of the whole-cell
extract and of dsLp showed a similar band pattern (Fig 1A and 1B) (meaning that most of the
proteins were solubilized within mixed micelles), dominated by a highly intense 63 KDa band
accompanied by heavy proteins and less intense lighter bands. The 63 KDa band could corre-
spond to the GP65 promastigote surface glycoprotein, already described in several species of
leishmania [43, 44]. Since the presence of NaChol interferes with protein colorimeric methods,
the densitometric intensity of the 63 KDa band was used to estimate the minimal protein con-
tent in dsLp and in nanovesicles. Structural properties of empty and dsLp-loaded nanonanove-
sicles are shown in Table 2.
dsLp-UDA and dsLp-UDL resulted to be*100 nm diameter nanovesicles, the same size
order of UDA and UDL. The potential structural destabilization on nanovesicles induced by
dsLp, was assessed by determining their size by DLS after 24 h; the presence of unilamellar
nanovesicles was further confirmed by TEM (Fig 2A and 2C) and by AFM (Fig 2B and 2D). By
DLS, the occurrence of heterogeneous populations having 15–25 nm diameter micelles grow-
ing at expenses of higher sized nanovesicles in particular for dsLp-UDA, was revealed. The size
heterogeneity of nanovesicles was less pronounced for films suspended with dsLp 1.25% w/v
NaChol (Fig 1D); for that reason, dsLp-nanovesicles were prepared with dsLp 1.25% w/v
Fig 1. Characterization of nanovesicles. (A) Gradient (7.5%-15%) PAGE of whole-cell extract (5 to 30 μg,
lanes 1 to 4) and dsLp (5 to 30 μg, lanes 6 to 9) from L. braziliensis, separated by molecular mass markers
(lane 5). (B) Calibration curve PAGE for dsLp (5–30 μg, lanes 1 to 4); molecular mass marker (lane 5); dsLp-
UDA (20 μl, lanes 6 and 7); dsLp-UDL (20 μl, lanes 8 and 9). (C) A plot of phospholipids from nanovesicles
extruded across 50 nm pore size membranes versus time. Values represented mean ± SD. (D)
Hydrodynamic diameter of dsLp and dsLp- nanovesicles measured by dynamic light scattering expressed in
intensity, volume and number mode. The percentages indicated the proportion of each structure.
doi:10.1371/journal.pone.0150185.g001
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NaChol. By AFM the dsLp-UDA–despite of its high Z potential-, appeared as aggregated nano-
vesicles, probably because of ionic bridging with CaCl2 employed to fix the nanovesicles to the
mica substrate.
The plot of phospholipids crossing a nanoporous barrier as a function of time is shown in
Fig 1C. The calculated D of dsLp-nanovesicles was reduced nearly 3.5 folds as compared to
empty nanovesicles, and nearly four folds above that of conventional non ultradeformable
nanovesicles (Table 2).
Young Modulus determination through AFM
The Young´s modulus (E) or longitudinal elastic modulus is the ratio between the increased
tension applied by traction (in the zone of elastic behavior of the material) (dσ) and the
Fig 2. Morphology of nanovesicles. (A and B) dsLp-UDA. (C and D) dsLp-UDL. (A and C) TEM images
(30000 X). (B and D) Three-dimensional AFM scans.
doi:10.1371/journal.pone.0150185.g002
Table 2. Structural features of nanovesicles.
Samples Mean size(nm)(polydispersity
index)
Z potential
(mV)
Protein concentration
(mg/ml)
Protein/ Phospholipid ratio
(% w/w)
D E (kPa)
L 109 ± 5(0.103) -10 ± 0.3 - - 765 1119 ± 242
UDL 110 ± 2(0.242) -12 ± 2 - - 3882 430 ± 137
UDA 130 ± 1(0.241) -35 ± 4 - - 4064 294 ± 177
dsLp 25 ± 3 (0.32) -19 ± 3.6 5 - - -
dsLp-UDL 99.86 ± 8.33(0.19) -11 ± 3.1 1.00 ± 0.60 4.84 ± 0.53 1100 161 ± 73
dsLp-
UDA
103.75 ± 1.85(0.21) -31 ± 3.7 0.85 ± 0.35 3.52 ± 0.25 1100 235 ± 69
Values represent means ± standard deviation (SD) (n = 8).
D, deformability; E, Young´s modulus; dsLp, detergent-solubilized L. braziliensis proteins; L, conventional liposomes; UDL, ultradeformable liposomes;
UDA, ultradeformable archaeosomes; dsLp-UDA, detergent-solubilized L. braziliensis proteins containing ultradeformable archaeosomes; dsLp-UDL,
detergent-solubilized L. braziliensis proteins containing ultradeformable liposomes.
doi:10.1371/journal.pone.0150185.t002
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resultant increased relative deformation (dε) (E: dσ/dε). E is a measure of a material rigidity:
the higher the elastic modulus is the more rigid material.
AFM is a growingly used technique to acquire soft matter images, such as molecular crys-
tals, proteins and live cells [45]. AFM is a well-suited technique for studying structural features
of nanovesicles enabling the simultaneous nanoscale analysis of shape and mechanical proper-
ties of the bilayers. It allows picking up surface topographical images with a space resolution
close to 1 Å and force vs. distance curves with a detection limit close to 10−12 N.
Our results showed in first place that E values for conventional nanovesicles are coincident
with bibliographic data (1.97 ± 0.75 x 106 Pa for adsorbed EggPC nanovesicles [46]. The Young
´s modulus for UDL and UDA were between 3 and 4 folds lower than that of conventional
nanovesicles. The difference was coincident with the higher D of UDA and UDL as compared
to conventional non ultradeformable nanovesicles determined by the Van der Berg method.
The Young´s module for dsLp- nanovesicles was in the order of the corresponding to empty
ultradeformable nanovesicles (Table 2).
Cell viability
Neither the empty or dsLp- nanovesicles nor dsLp in the range of tested concentrations were
cytotoxic to macrophages, keratinocytes or BMDC (Fig 3).
Pro-inflammatory cytokines induction on BMDC and J774A1 cells and
uptake by BMDC
In (Fig 4A–4D) the cytokine levels on J774A1 macrophages supernatants induced by dsLp and
dsLp-nanovesicles are depicted. Neither UDL, UDA nor dsLp-UDL induced pro inflammatory
cytokines. dsLp alone, at 50 μg/ml induced an early onset of IL-12p40 followed by high level of
IL-6; no TNF-α or IL-1 β induction was registered. dsLp-UDA however, was the only to induce
an early onset of IL-6, IL-12p40 and TNF- α, followed 34 h later by high IL-1 β titers.
The cytokine response of BMDC to dsLp-UDA however, was milder and transient than in
J774A1cells: no IL1-β or TNF-α were detected, low and transient titers of IL-6 and IL-12p40,
this last fading after 48h (Fig 4E and 4F).
In Fig 5, the uptake of empty nanovesicles by BMDC is shown; a nearly eightfold higher
uptake of UDA compared to UDL is observed.
Fluorescently labeled UDA or UDL were incubated 1, 3 or 5 h with BMCD at 37°C. The
cells fluorescence resulting from internalized nanovesicles was quantified by flow cytometry.
Immunization
The humoral immune response generated after topical weekly applications of dsLp-nanovesicles
was compared to that generated after topical dsLp and by i.m. alum adsorbed dsLp, as a positive
control of dsLp immunogenicity. The titers rose by topical dsLp-UDA were 1 log higher than
those of dsLp-UDL. The response remained constant up to the day 49, while that of dsLp-UDL
faded rapidly within 3 weeks (Fig 6A). The topical application of dsLp did not raise measurable
IgG titers. None of the topical administrations induced IgA titers in salivary washes.
In mice, IgG2a produced from Th1 cells indicates cell-mediated immunity, and IgG1 pro-
duced from Th2 cells indicates humoral immunity. Therefore, the balance between Th1 and
Th2 cells (Th1/Th2 ratio) can be represented as the IgG2a/IgG1 ratio. The isotype analysis of
samples taken the 49 day showed that i.m alum adsorbed dsLp raised a mixed isotype profile
with IgG1/IgG2a ~1. In contrast, dsLp-UDA induced preferentially the IgG2a isotype, suggest-
ing a Th1 polarized response (Fig 6B).
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Discussion
The success of needle free vaccination largely depends on counting on carriers ultradeformable
enough to efficiently penetrate the intact stratum corneum to bring their payload across the
skin. In a previous work, we found that UDA carrying ovalbumin (ova, a 42.7 KDa, 6 nm diam-
eter globular protein) (ova-UDA) raised an IgG2a-biased anti-ova systemic response ten folds
higher than ova-UDL, after topical application on Balb/c mice [19]. The immune response to
topical stimulus was enabled by the ultradeformable nanovesicles delivering ova across and
beyond the stratum corneum, presumably through the lipid canyons that separate keratinocyte
clusters of the skin upper layers [[47]. Such canyons occasionally extend down to depths com-
parable to that of the dermal–epidermal junction below the flat surface regions in porcine and
human skin [48, 49].Upon topical non-occlusive application, the fluorescence of Alexa Fluor
647 labeled ova within UDL or UDA, allows to indirectly estimate a rough canyons thickness
of 50–100 μm [50]. This is in good agreement with the 10–25 μmwidth canyons separating
keratinocyte clusters of 100–250 μm diameter, recently assessed by stimulated Raman scatter-
ing microscopy [[50]. Canyons, despite of being wide enough so as to allow the passage of 100
Fig 3. Cytotoxicity of empty and dsLp- nanovesicles. (A) J774 cells. (B) HaCaT cells. (C) Bone marrow
derived dendritic cells (BMDC). Values represent mean ± SD (n = 5). Not significant differences were found
between treatments and control cells.
doi:10.1371/journal.pone.0150185.g003
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Fig 4. Cytokine levels in J774A1macrophages and BMDC supernatants. Cells were incubated along 14 and 48 h with UDA, UDL, dsLp-UDA, dsLp-
UDL, dsLp alone and LPS (TLR4 agonist) as positive control. The absorbance of the basal condition (non-stimulated cells, incubated with culture media
Adjuvancy of Ultradeformable Archaeosomes
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nm diameter nanovesicles, are filled with lipids enclosing water nanochannels, that nanovesi-
cles are thought to penetrate [51]. However, these extremely thin pathways [48, 52]. scarcely
distributed across the canyons, together with the impaired material diffusion through the lipid
filling organized in orthorhombic lateral packing lamellas [53], and the intercellular unions
(corneo-desmosomes in stratum corneum, tight junctions in upper viable epidermis) [54], may
constitute a physical constraint to the penetration of bulky structures carried by UDL or UDA
[49] (Fig 7).
An interesting example is constituted by aqueous suspension of Quantum Dots (QDots,
pegylated CdSe/ZnS core/shell 12 nm x 6 nm ellipsoidal bulky stiff nanoparticles), that upon
topical application do penetrate the skin up to the viable epidermis. When loaded within ultra-
deformable nanovesicles however, the QDots remain stacked at the first layers of the stratum
corneum and do not penetrate [55]. Such observation challenges the notion of needing ultrade-
formable nanovesicles to grant the penetration of particulate cargo. It suggests also that factors
such as size, shape and even stiffness of particulate cargo may account for its penetration,
beyond the simple association to ultradeformable nanovesicles (Fig 7). According to this view,
the dsLp used in this work, of size in the range of a QD (nearly 3 folds higher than ovalbumin),
were good candidates to stack on the first stratum corneum layers despite of loaded within
ultradeformable nanovesicles. Indeed, such phenomenon was suspected while estimating
bilayer deformability at the first steps of dsLp-nanovesicles structural characterization. When
the deformability (D, a parameter inversely proportional to the Young modulus (E)) of dsLp-
nanovesicles was measured by the Van der Bergh method, we found it lower than that of
empty ones. On the contrary, the deformability of dsLp-nanovesicles determined by AFM was
similar to that of empty ones. This apparent discrepancy would obey to a stacking of the over-
sized (~ 25 nm) dsLp mixed micelles during extrusion, which caused a reduced phospholipid
flux. The calculated D would result from a steric hindrance caused by packing constraints of
cargo and not from reduced bilayer deformability. Since the second method measures the can-
tilever deflection on surface patches of individual nanovesicles, the AFM is thus a more realistic
determination of nanovesicles deformability carrying oversized cargoes. As indicated above,
as negative control) was subtracted to that of each cytokine concentration. Each point represents the media of n = 3 and its corresponding SD. ** denotes
p < 0.01, *** denotes p < 0.001; n.s. not significant. (A) TNF- α levels in J774A1 supernatants. (B) IL-12p40 levels in J774A1 supernatants. (C) IL-6 levels in
J774A1 supernatants. (D) IL-1β levels in J774A1 supernatants. (E) IL-12p40 levels in BMDC supernatants. (F) IL-6 levels in BMDC supernatants.
doi:10.1371/journal.pone.0150185.g004
Fig 5. Uptake of Rhodamine–PE labeled UDA and Rhodamine–PE labeled UDL by BMDC, determined
by flow cytometry. Values represent mean ± SD, ** denotes p < 0.01
doi:10.1371/journal.pone.0150185.g005
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the physical constraint imposed by dsLp to nanovesicles extruded across 50 nm filter pores,
suggested that in vivo the dsLp- ultradeformable nanovesicles could end up stacked within the
stratum corneum the same as QD-UDL, thus spoiling the topical immunization. In our experi-
mental setting however, after dropping a weekly dosage of dsLp-nanovesicles on the intact skin
of Balb/c mice, dsLp and dsLp-UDL failed at inducing systemic IgG titers, but dsLp-UDA was
the only topical formulation that successfully raised a sustained systemic antigen specific
response. Despite of its low protein/lipid ratio (3.5% vs 12.5% for ova-UDA), dsLp-UDA
induced 1 log lower serum titers than i.m. dsLp-alum adsorbed, but was tenfold more immuno-
genic than ova-UDA (that rendered 2 log lower serum titers than i.m. ova-alum adsorbed
[19]). Topical dsLp-UDA induced IgG2a only (which in mice suggests a Th1 biased response,
as required for vaccination against Leishmania) [6], whereas the response to i.m. dsLp alum-
adsorbed was a mixed IgG isotype.
As previously determined in [56]., J774A1 macrophages capture empty UDA much more
extensively than UDL. UDA in other words is a more efficient carrier for material delivery to
phagocytic cells than UDL. Here UDA and UDL showed to be were non immunogenic, since
no pro inflammatory cytokines were detected in macrophages supernatants; instead, macro-
phages responded only to dsLp and dsLp-nanovesicles. The immune responses to dsLp-UDL,
Fig 6. Serum IgG titers after topical application of dsLp-nanovesicles and intramuscular application
of dsLp adsorbed in alum. (A) IgG isotypes. (B) Values represent mean ± SD. ** denotes p < 0.01, ***
denotes p < 0.001 vs dsLp-UDL and dsLp.
doi:10.1371/journal.pone.0150185.g006
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however were of low intensity and faded soon. DsLp-UDA was the only capable of inducing an
immediate secretion of IL-6, IL-12p40 and TNF-α, followed by high TNF-α and IL-1β titers in
J774A1 cells. The response was aroused with lower amounts of proteins (28 μg/ml dsLp as
dsLp-UDA vs 50 μg/ml dsLp alone), suggesting that UDAmay enhance the immunogenicity of
dsLp.
In particular, TNF-α level raised by dsLp-UDA was not only higher than the induced by
dsLp alone, but also by the classical TLR4 ligand LPS (the source of the potent MPLA, a well-
known immunostimulatory adjuvant present in commercial emulsions such as AS04). Interest-
ingly, dsLp-UDA was the only stimulus that induced a remarkable elevation of IL-1β. Similar
to TNF-α, IL-1β is a major pro-inflammatory cytokine considered as an alarm signal secreted
by macrophages. IL-1β initiates and propagates inflammation by inducing the expression of
adhesion molecules on endothelial cells and leukocytes [57, 58]. This cytokine was reported to
be involved in a protective immune response against Leishmania spp. IL-1β affects the pathoge-
nicity of leishmania by generating an inflammatory response in afflicted tissues and by modu-
lating adaptive T cell mediated immune responses, which act to limit parasite dissemination
Fig 7. Scheme depicting the main structural sections of the skin: stratum corneum (SC), viable
epidermis and dermis, and barriers to permeation-penetration (not a scale): The diffusive pathway
across the lipids of the SC is mediated by disordered bilayers, represented by the X-ray diffraction pattern
corresponding to the lateral packing in liquid phase of bilayers shown in a) (distance between planes*0.46
nm). Bilayers b) and c) with more organized lateral packing (distance between planes 0.41 and 0.41–0.37
nm, respectively), not involved in diffusion across the skin. The interaction between ultradeformable
nanovesicles (UDN), conventional liposomes, hydrophilic solutes and lipids at the SC surface is also
represented. Ultradeformable nanovesicles and hydrophilic solutes penetrate across hydrophilic leads in the
canyons in-between corneocyte clusters. A scheme of ultradeformable nanovesicles and associated cargo
crossing an hydrophilic channel in the SC. The colloidal structure is lost below the surface. The associated
cargo penetrates along with the lipid bilayers. No endocytic uptake occurs at I and II levels since the SC is
made of dead corneocytes. Below 10 μm depth, endocytic uptake of material penetrating across hydrophilic
channels accessing the viable epidermis may occur. Epidermis: stratum basale (SB), stratum spinosum (SS),
stratum granulosum (SG). (Dermo epidermal basal membrane is represented as black line and the reticular
capillary plexus in the dermis as red dots)
doi:10.1371/journal.pone.0150185.g007
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[59, 60]. Substantive experimental evidence suggests that the MyD88-dependent Toll-like
receptor (TLR) signalling, a classical recognition pathway for macrophage activation, is
bypassed by the immunologically silent Leishmania spp. [61–66]. Instead, IL-1β has recently
been described as initiator of the protective immune response. In particular, the NLRP3 (a
member of the Nod-like receptor (NLR) family that senses microbes and cell damage) medi-
ated activation of the inflammasome and subsequent induction of IL-1β signalling, was found
to play a key role in host resistance to MCL [67]. The inflammasome are multimeric complexes
of proteins, assembled in the host cell cytoplasm in response to specific stress signals or con-
tamination of the cytoplasm by microbial molecules. The canonical inflammasomes are com-
posed of at least three main components: an inflammatory caspase (caspase-1, caspase-11), an
adapter molecule (such as ASC), and a sensor protein (such as the NLR family members
NLRP1, NLRP3, NLRP12; also NAIP1, NAIP2, NAIP5, or AIM2 [68, 69]. Once activated, cas-
pase-1 induces processing and secretion of IL-1β, which is transcriptionally regulated when
microbial components are sensed by pattern recognition receptors [70]. Notably, the activation
of the inflammasome leads to autonomous macrophage mechanisms that culminate with the
restriction of intracellular parasite replication. These processes involve the regulation of IFN-γ
and processing of IL-1β, which facilitates the expression of NOS2, an enzyme that is required
for NO-mediated restriction of Leishmania replication in macrophages [71–73]. The fact that
IL-1β signalling is crucial for the determination of the severity of disease in humans, under-
scores an important role for the inflammasome-dependent restriction of Leishmania spp. repli-
cation [74, 75].
Unpublished research from our laboratory [76] suggests that one or more archaeolipids
present in the total polar lipids of UDA-presumably the main component PGP Me- are ligand
of the Scavenger Receptor Class A I/II (SRAI/II). The SRAI/II is a pattern recognition receptor
mainly expressed by macrophages, vascular smooth muscle cells and endothelial cells, primar-
ily involved in endocytic uptake of particulate material (lysosomal enzymes, oxidised acetylated
lipoproteins, LPS, bacteria) [77]. Since UDA is pronouncedly captured by macrophages upon
SRAI/II recognition, the amount of dsLp antigens available to interact with NLRP3– a cyto-
plasmic receptor- would be higher if delivered as dsLp-UDA, than as dsLp alone or dsLp-UDL.
This may account for the increase of IL-1β induced on J774A1 cells by dsLp-UDA.
On the other hand, the expression of SR A by BMCD is highly dependent on the isolation
protocol employed [78, 79]. BMDC were also reported to display NLRP3 mediated inflamma-
some activation in front to several stimuli [80, 81]. If well the expression of SRA was not
screened here, the BMDC have the potential to react similar to macrophages in front to UDA/
dsLp-UDA. An extensive uptake of UDA however, was the only response recorded by BMDC.
Less likely, a concomitant production of pro inflammatory cytokines to dsLp-UDAmay have
occurred in a temporal pattern different to that recorded at 14 or 48 h. These findings suggest
the cells involved in an in vitro primary response to dsLp-UDA were the macrophages. In vivo,
the proteins in dsLp alone were reported to induce IL-12 cytokines [49]. Overall, this first
approach showed that the topical Balb/c mice immunization with dsLp-UDA generated a Th1
biased response, as determined by the serum isotypes of dsLp-specific IgG. Further insights are
needed to find out if the high UDA-mediated dsLp delivery that led to macrophages secretion
of IL-1β, may contribute to an in vivo lethal response to leishmania parasites.
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